Takeda, Cognition Kit collaborate on wearable app for depression

Takeda Pharmaceuticals and Cognition Kit, a wearable platform that monitors brain health, have partnered for a pilot study on major depressive disorder.

Advertisement

The study, which will involve 30 participants, will investigate the use of a specially designed app on an Apple Watch wearable. The app will collect real-time mental health data in an effort to assess cognitive function in the participants, all of whom have a clinical diagnosis of mild to moderate depression and have been prescribed an antidepressant.

The goal of the study is to understand how measures of mood and cognition on wearable technology compare to more traditional neuropsychological testing and patient-reported assessments.

More articles on health IT:
The 8 most common healthcare apps clinicians want to create
IBM Watson Health medical imaging collaborative adds 8 members
Philips rolls out Jovia Coach app for Type 2 diabetes

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Health IT

Advertisement

Comments are closed.